NCT04579757 2025-05-08Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid TumorsHutchmedPhase 1/2 Terminated87 enrolled 29 charts
NCT04653480 2023-07-17Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRCZhejiang UniversityPhase 2 Unknown61 enrolled